补充成分3 适应脑脊液的瘤转移
Adrienne Boire1, Yilong Zou2, Jason Shieh2
1Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cell
|March 12, 2017
概括
癌症扩散到脑液 (脑膜转移) 是由补体C3驱动的. 在临床前模型中,针对C3信号抑制了这种致命的癌症进展.
科学领域:
- 癌症学
- 免疫学
- 神经科学
背景情况:
- 乳腺癌转移 (癌症扩散到脑脊液) 是晚期癌症的致命并发症.
- 驱动乳腺瘤转移的机制尚不清楚.
- 癌细胞必须适应独特的脑脊液微环境.
研究的目的:
- 阐明瘤转移的分子机制.
- 确定在脑脊液中促进癌细胞生存和生长的关键因素.
- 探索治疗策略以向乳腺瘤转移.
主要方法:
- 使用已知潜入脑脊液的肺癌和乳腺癌细胞系.
- 开发了乳腺瘤转移的临床前模型.
- 在癌细胞和脑脊液中量化补充成分3 (C3) 表达.
- 研究C3在破坏血脑脊液屏障中的作用.
- 评估了针对C3信号的治疗效果.
主要成果:
- 补充成分3 (C3) 在瘤转移模型中升级,对脑脊液中的癌症生长至关重要.
- 脑脊液中的癌细胞产生C3,与患者的疾病进展相关.
- 在原发性瘤中,C3表达预测了瘦骨性复发.
- 癌症衍生的C3激活了胆脉中的C3a受体,破坏了血脑脊液屏障.
- 这种干扰使得血衍生物进入脑脊液,促进癌细胞的增殖.
- 在临床前模型中,药物抑制C3信号显示出治疗效益.
结论:
- 补充成分3 (C3) 在促进瘦身膜转移方面起着至关重要的作用.
- 血脑脊液屏障的C3介导破坏是促进脑脊液癌症生长的关键机制.
- 向C3信号是一种有前途的治疗策略,用于管理乳腺转移.
相关概念视频
Cerebrospinal Fluid
7.3K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
7.3K
Complement System
11.5K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
11.5K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cranial and Spinal Meninges
4.5K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
4.5K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
The Blood-brain Barrier
54.3K
Overview
54.3K


